636 related articles for article (PubMed ID: 26507691)
1. All roads lead to PP2A: exploiting the therapeutic potential of this phosphatase.
Sangodkar J; Farrington CC; McClinch K; Galsky MD; Kastrinsky DB; Narla G
FEBS J; 2016 Mar; 283(6):1004-24. PubMed ID: 26507691
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic targeting of PP2A.
O'Connor CM; Perl A; Leonard D; Sangodkar J; Narla G
Int J Biochem Cell Biol; 2018 Mar; 96():182-193. PubMed ID: 29107183
[TBL] [Abstract][Full Text] [Related]
3. Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancer.
Seshacharyulu P; Pandey P; Datta K; Batra SK
Cancer Lett; 2013 Jul; 335(1):9-18. PubMed ID: 23454242
[TBL] [Abstract][Full Text] [Related]
4. Oncoprotein CIP2A is stabilized via interaction with tumor suppressor PP2A/B56.
Wang J; Okkeri J; Pavic K; Wang Z; Kauko O; Halonen T; Sarek G; Ojala PM; Rao Z; Xu W; Westermarck J
EMBO Rep; 2017 Mar; 18(3):437-450. PubMed ID: 28174209
[TBL] [Abstract][Full Text] [Related]
5. Structure, regulation, and pharmacological modulation of PP2A phosphatases.
Lambrecht C; Haesen D; Sents W; Ivanova E; Janssens V
Methods Mol Biol; 2013; 1053():283-305. PubMed ID: 23860660
[TBL] [Abstract][Full Text] [Related]
6. Multiple pathways regulated by the tumor suppressor PP2A in transformation.
Westermarck J; Hahn WC
Trends Mol Med; 2008 Apr; 14(4):152-60. PubMed ID: 18329957
[TBL] [Abstract][Full Text] [Related]
7. Functional importance of PP2A regulatory subunit loss in breast cancer.
Watt LF; Panicker N; Mannan A; Copeland B; Kahl RGS; Dun MD; Young B; Roselli S; Verrills NM
Breast Cancer Res Treat; 2017 Nov; 166(1):117-131. PubMed ID: 28744751
[TBL] [Abstract][Full Text] [Related]
8. The role of PP2A A subunits in tumor suppression.
Sablina AA; Hahn WC
Cell Adh Migr; 2007; 1(3):140-1. PubMed ID: 19262135
[TBL] [Abstract][Full Text] [Related]
9. Phosphoproteome and drug-response effects mediated by the three protein phosphatase 2A inhibitor proteins CIP2A, SET, and PME-1.
Kauko O; Imanishi SY; Kulesskiy E; Yetukuri L; Laajala TD; Sharma M; Pavic K; Aakula A; Rupp C; Jumppanen M; Haapaniemi P; Ruan L; Yadav B; Suni V; Varila T; Corthals GL; Reimand J; Wennerberg K; Aittokallio T; Westermarck J
J Biol Chem; 2020 Mar; 295(13):4194-4211. PubMed ID: 32071079
[TBL] [Abstract][Full Text] [Related]
10. Non-genomic mechanisms of protein phosphatase 2A (PP2A) regulation in cancer.
Kauko O; Westermarck J
Int J Biochem Cell Biol; 2018 Mar; 96():157-164. PubMed ID: 29355757
[TBL] [Abstract][Full Text] [Related]
11. HEAT repeat 1 motif is required for B56γ-containing protein phosphatase 2A (B56γ-PP2A) holoenzyme assembly and tumor-suppressive function.
Nobumori Y; Shouse GP; Fan L; Liu X
J Biol Chem; 2012 Mar; 287(14):11030-6. PubMed ID: 22315229
[TBL] [Abstract][Full Text] [Related]
12. Targeting PP2A in cancer: Combination therapies.
Mazhar S; Taylor SE; Sangodkar J; Narla G
Biochim Biophys Acta Mol Cell Res; 2019 Jan; 1866(1):51-63. PubMed ID: 30401535
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of the catalytic subunits for PP-1 and PP-2A and the regulatory subunits for PP-2A in mouse eye.
Liu WB; Li Y; Zhang L; Chen HG; Sun S; Liu JP; Liu Y; Li DW
Mol Vis; 2008 Apr; 14():762-73. PubMed ID: 18432318
[TBL] [Abstract][Full Text] [Related]
14. Autophosphorylation of ataxia-telangiectasia mutated is regulated by protein phosphatase 2A.
Goodarzi AA; Jonnalagadda JC; Douglas P; Young D; Ye R; Moorhead GB; Lees-Miller SP; Khanna KK
EMBO J; 2004 Nov; 23(22):4451-61. PubMed ID: 15510216
[TBL] [Abstract][Full Text] [Related]
15. Targeting c-MYC by antagonizing PP2A inhibitors in breast cancer.
Janghorban M; Farrell AS; Allen-Petersen BL; Pelz C; Daniel CJ; Oddo J; Langer EM; Christensen DJ; Sears RC
Proc Natl Acad Sci U S A; 2014 Jun; 111(25):9157-62. PubMed ID: 24927563
[TBL] [Abstract][Full Text] [Related]
16. Roles and regulation of protein phosphatase 2A (PP2A) in the heart.
Lubbers ER; Mohler PJ
J Mol Cell Cardiol; 2016 Dec; 101():127-133. PubMed ID: 27832939
[TBL] [Abstract][Full Text] [Related]
17. The interaction of SET and protein phosphatase 2A as target for cancer therapy.
Dacol EC; Wang S; Chen Y; Lepique AP
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188578. PubMed ID: 34116173
[TBL] [Abstract][Full Text] [Related]
18. [Protein phosphatase 2A: its structure, function and activity regulation].
Liu WJ; Shen Y; Ding J
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Feb; 35(2):105-12. PubMed ID: 12545214
[TBL] [Abstract][Full Text] [Related]
19. FAM122A, a new endogenous inhibitor of protein phosphatase 2A.
Fan L; Liu MH; Guo M; Hu CX; Yan ZW; Chen J; Chen GQ; Huang Y
Oncotarget; 2016 Sep; 7(39):63887-63900. PubMed ID: 27588481
[TBL] [Abstract][Full Text] [Related]
20. Biased holoenzyme assembly of protein phosphatase 2A (PP2A): From cancer to small molecules.
Haanen TJ; O'Connor CM; Narla G
J Biol Chem; 2022 Dec; 298(12):102656. PubMed ID: 36328247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
